Ligand Pharmaceuticals/ US53220K5048 /
10/06/2024 21:59:59 | Var. -1.79 | Volume | Denaro- | Lettera- | Max | Min |
---|---|---|---|---|---|---|
79.72USD | -2.19% | 13,178 Fatturato: 1.04 mill. |
-Quantità in denaro: - | -Quantità in lettera: - | 79.98 | 77.15 |
Newsfile Corp
05:22
"Winds of Change" Celebrating Kazakhstan's National Parks at The Canvas 3.0 Exhibition June 8th - Ju...
GlobeNewswire
05:16
Northwest China's Yangling setting benchmark for SCO agriculture technology cooperation for shared g...
GlobeNewswire
04:50
Flash News: OKX Announces Participation in Launch of Lagrange Labs' First Production-Ready ZK Prover...
GlobeNewswire
04:19
President Lula to Speak at FII PRIORITY Rio de Janeiro Summit at the Copacabana Palace Wednesday
GlobeNewswire
03:00
AUTODESK ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been F...
GlobeNewswire
03:00
MARINUS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Fi...
GlobeNewswire
02:00
ROSEN, LEADING INVESTOR COUNSEL, Encourages Teladoc Health, Inc. Investors to Secure Counsel Before ...
GlobeNewswire
02:00
ROSEN, A LONGSTANDING LAW FIRM, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel...
GlobeNewswire
01:19
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Masimo Corporation Investors to Inquire About Securities...
GlobeNewswire
01:12
CoreCivic Receives Termination Notice From U.S. Immigration and Customs Enforcement At South Texas F...
GlobeNewswire
00:42
ROSEN, LEADING INVESTOR COUNSEL, Encourages Humana Inc. Investors to Secure Counsel Before Important...